Oral Fluid Sars-CoV-2 Ab Rapid test
Not Applicable
Completed
- Conditions
- Health Condition 1: A00-B99- Certain infectious and parasitic diseasesHealth Condition 2: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2020/06/025674
- Lead Sponsor
- Diabetes Research Society
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 150
Inclusion Criteria
1. 18 years or older, men and women
2. Subjects suspected or with symptoms of Sars-CoV-2
3. Subjects, 3 days after the onset of symptoms
4. Smoking or non-smoking
5. Subjects willing for participating in the study and providing informed consent
Exclusion Criteria
Subjects on ventilators or lung support
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method There is a significant positive correlation between presence or absence of (blood and salivary) antibodies (against Sars-CoV-19 virus) and, severity and duration of disease after onset of symptoms. It is expected to initially observe this relationship most strongly in individuals who have specific disease (RT-PCR confirmed COVID-19 disease) within 7 days of onset, and these antibodies continue to remain positive in recovery period, 21 days and much later for many more weeks.Timepoint: June 16-July 31, 2020
- Secondary Outcome Measures
Name Time Method (blood and salivary) antibodies (against Sars-CoV-19 virus) and, severity and duration of disease after onset of symptoms. It is expected to initially observe this relationship most strongly in individuals who have specific disease (RT-PCR confirmed COVID-19 disease) within 7 days of onset, and these antibodies continue to remain positive in recovery period, 21 days and much later for many more weeks.Timepoint: June 16-July 31, 2020